KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Capital Expenditures (2016 - 2025)

Encompass Health (EHC) has disclosed Capital Expenditures for 15 consecutive years, with $229.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 15.4% year-over-year to $229.3 million, compared with a TTM value of $736.4 million through Dec 2025, up 14.61%, and an annual FY2025 reading of $736.4 million, up 14.61% over the prior year.
  • Capital Expenditures was $229.3 million for Q4 2025 at Encompass Health, up from $187.1 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $229.3 million in Q4 2025 and bottomed at $98.8 million in Q1 2021.
  • Average Capital Expenditures over 5 years is $154.6 million, with a median of $149.5 million recorded in 2022.
  • Peak annual rise in Capital Expenditures hit 243.99% in 2021, while the deepest fall reached 52.5% in 2021.
  • Year by year, Capital Expenditures stood at $213.4 million in 2021, then dropped by 1.97% to $209.2 million in 2022, then rose by 1.2% to $211.7 million in 2023, then fell by 6.14% to $198.7 million in 2024, then rose by 15.4% to $229.3 million in 2025.
  • Business Quant data shows Capital Expenditures for EHC at $229.3 million in Q4 2025, $187.1 million in Q3 2025, and $156.9 million in Q2 2025.